<DOC>
	<DOCNO>NCT00782431</DOCNO>
	<brief_summary>The purpose study demonstrate effectiveness ( seroprotection seroconversion measure hemagglutination inhibition [ HI ] assay ) investigational Vero cell-derived , trivalent , seasonal influenza vaccine adult 50 year age old . Subjects randomize double-blind fashion receive single intramuscular injection either investigational vaccine license egg-derived seasonal influenza vaccine . Blood drawn subject determination HI antibody titer Days 0 21 , body temperature injection site reaction monitor daily 7 day . In addition , subject monitor adverse event rise body temperature Day 21 Day 180 .</brief_summary>
	<brief_title>Immunogenicity Safety Study Inactivated Influenza Vaccine ( Split Virus , Vero Cell Derived ) Adults Aged 50 Years Older</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Are 50 year age old day screen Have understanding study , agree provision , ability adhere provision study give write informed consent prior study entry If female capable bearing child , negative urine pregnancy test result within 24 hour prior vaccination Study Day 0 agree employ adequate birth control measure . History severe allergic reaction anaphylaxis egg protein component Vero cellderived influenza vaccine eggderived influenza vaccine Oral temperature &gt; = 99.5°F ( 37.5°C ) day vaccination study ( Note : Subjects meet exclusion criterion may reschedule vaccination study entry later date certain requirement [ study protocol ] meet ) Rash dermatologic condition tattoo may interfere injection site reaction rating Blood transfusion immunoglobulins receive within 90 day study entry Live vaccine receive within 4 week inactivate vaccine subunit vaccine receive within 2 week study entry Previous vaccination influenza 2008/2009 northern hemisphere influenza season Functional surgical asplenia ( e.g . history hemoglobinopathy , leukemia , lymphoma ) Diagnosed immunodeficiency result pathological condition Pharmacologically induce immunodeficiency result prescribe administration corticosteroid ( e.g. , systemic administration corticosteroid inhale dose equivalent 800 mg beclomethasone dipropionate ) chemotherapeutics result radiation therapy modality capable alter normal immunologic response Known suspect problem drug alcohol abuse Investigational drug receive within 6 week prior study entry concurrent participate clinical study include administration investigational product Subjects member team conduct study dependent relationship study investigator . Dependent relationship include close relative ( i.e. , child , spouse/partner , sibling , parent ) well employee investigator .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>